Prostate cancer — all decisions

The Board granted service connection for prostate cancer, resolving reasonable doubt in the Veteran's favor based on evidence of in-service exposure to carcinogens.

The Board granted service connection for diabetes mellitus type II, hepatitis B, a liver condition (hepatic steatosis and cirrhosis) secondary to service-connected hepatitis B, hypertension, prostate cancer, voiding dysfunction as secondary to service-connected prostate cancer, and erectile dysfunction as secondary to service-connected prostate cancer. The claim for anemia was remanded.

The Board dismissed the claim for service connection for prostate cancer and denied an earlier effective date for urinary incontinence residuals of adenocarcinoma of the prostate (s/p prostatectomy).

The Board remands the claims for service connection for prostate cancer and skin cancer due to ionizing radiation exposure, as a VA examination is needed to determine their likely etiology.

The Board granted a 100 percent rating for prostate cancer status post radical prostatectomy from April 27, 2023 to February 24, 2025, but dismissed the appeal as moot beginning February 25, 2025.

The Board granted service connection for residuals of prostate cancer, to include urinary incontinence, based on the Veteran's exposure to ionizing radiation during active service.

The Board remanded the Veteran's claim for compensation under 38 U.S.C. § 1151 for residuals of prostate cancer due to inadequate VA medical opinions. A new VA medical examination and opinion is required to determine whether VA's failure to timely diagnose and treat the Veteran's prostate cancer proximately caused the additional disability.

The Board denied service connection for prostate cancer, major depressive disorder, sleep apnea, headaches, substance abuse, and chronic pain syndrome as the evidence did not support a finding that these conditions were incurred in or aggravated by the Veteran's active service, including exposure to contaminated water at Camp Lejeune.

The Board granted service connection for prostate cancer, finding a nexus to toxic exposures in service at Camp Lejeune.

The Veteran's service-connected voiding dysfunction, alone, precludes him from earning substantially gainful income from employment, and he is granted a total disability rating based on individual unemployability (TDIU) beginning July 28, 2021, along with special monthly compensation for statutory housebound status.

The Board remands the claim for service connection for prostate cancer to obtain an addendum medical opinion regarding its etiology, including jet fuel exposure.

The Board granted a 100 percent rating for prostate cancer status post radical prostatectomy from April 27, 2023 to February 24, 2025, but dismissed the appeal as moot beginning February 25, 2025.

The Board granted service connection for prostate cancer, resolving reasonable doubt in favor of the Veteran.

The Board granted service connection for prostate cancer and hypertension based on the evidence showing in-service exposures to non-tactical herbicides, which are linked to these conditions.

The Board denied entitlement to a total disability rating based on individual unemployability (TDIU), on an extra-schedular basis, prior to July 23, 2019.

The Board remands the claims for service connection for sleep apnea, prostate cancer, and diabetes mellitus type II due to an incomplete review of potential Agent Orange exposure during the Veteran's service in Korea.

The Board denied service connection for toe amputation, diabetes, high blood pressure, kidney disease, and prostate cancer as they were not shown to have begun in service or be related to service, including by exposure to contaminated water at Camp Lejeune.

The appeal was dismissed due to the Veteran's death during the pendency of the appeal.

The Board denied service connection for diabetes mellitus, prostate cancer, and an increased rating for other specified trauma- and stressor-related disorder. The Veteran's claims for service connection for degenerative joint disease of multiple joints were remanded.

The Board granted service connection for prostate cancer on a basis other than as pursuant to the PACT Act, including due to exposure to herbicide agents.